Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities

Molecules. 2021 Mar 21;26(6):1754. doi: 10.3390/molecules26061754.

Abstract

Since the emergence of severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2) first reported in Wuhan, China in December 2019, COVID-19 has spread to all the continents at an unprecedented pace. This pandemic has caused not only hundreds of thousands of mortalities but also a huge economic setback throughout the world. Therefore, the scientific communities around the world have focused on finding antiviral therapeutic agents to either fight or halt the spread of SARS-CoV-2. Since certain medicinal plants and herbal formulae have proved to be effective in treatment of similar viral infections such as those caused by SARS and Ebola, scientists have paid more attention to natural products for effective treatment of this devastating pandemic. This review summarizes studies and ethnobotanical information on plants and their constituents used for treatment of infections caused by viruses related to the coronavirus family. Herein, we provide a critical analysis of previous reports and how to exploit published data for the discovery of novel therapeutic leads to fight against COVID-19.

Keywords: ACE2; COVID-19; SARS-CoV; enzyme inhibitors; medicinal plants; phytochemicals.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Biological Products / chemistry*
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use
  • Humans
  • Plants, Medicinal / chemistry*
  • Secondary Metabolism
  • Severe Acute Respiratory Syndrome / drug therapy*
  • Severe acute respiratory syndrome-related coronavirus / drug effects
  • Severe acute respiratory syndrome-related coronavirus / metabolism

Substances

  • Antiviral Agents
  • Biological Products